https://www.selleckchem.com/pr....oducts/srt2104-gsk22
OAT patients and clinicians can weigh the risks and benefits of benzodiazepines differently leading to a difference in treatment goals. The risk-benefit analysis of benzodiazepine prescribing may depend on whether the patient is engaged in opioid treatment. Future work among patients and clinicians is warranted to determine how to better balance patient and clinician priorities in order to deliver safer prescribing practices and maintain patient engagement in care. OAT patients and clinicians can weigh the risks and benefits
Like
Comment
Share
